Revolution Medicines, Inc. RVMD EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Revolution Medicines, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Revolution Medicines, Inc.’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →
Ask your AI about Revolution Medicines, Inc.'s ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revolution Medicines, Inc.'s EV / sales?
- Revolution Medicines, Inc. (RVMD) reported EV / sales of 10,042.9× in Q3 2024.
- How has Revolution Medicines, Inc.'s EV / sales changed year-over-year?
- Revolution Medicines, Inc.'s EV / sales increased by 9533.4% year-over-year, from 104.3× to 10,042.9×.
- What is the long-term trend for Revolution Medicines, Inc.'s EV / sales?
- Over 2 years (2021 to 2023), Revolution Medicines, Inc.'s EV / sales has grown at a 45.8% compound annual growth rate (CAGR), from 256.8× to 545.7×.
- What does EV / sales mean?
- What the whole business costs relative to its annual sales.
- How do you interpret EV / sales?
- A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
- How does EV / sales compare across companies?
- Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.